Kate Hermans - 07 Jun 2023 Form 4 Insider Report for Ambrx Biopharma Inc.

Role
Director
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Kate Hermans
Issuer symbol
N/A
Transactions as of
07 Jun 2023
Net transactions value
$0
Form type
4
Filing time
09 Jun 2023, 16:05:15 UTC
Previous filing
31 Jan 2023
Next filing
07 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMAM Ordinary Shares Award $0 +85,000 $0.000000 85,000 07 Jun 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents seven (7) Ordinary Shares of the Issuer.
F2 Represents grant of Restricted Stock Units (the "RSUs") payable solely in Ordinary Shares of the Issuer that vest as follows: on the earlier of (i) the one year anniversary of the date of grant and (ii) the day before the next annual general meeting.